Ketcher 03151912012D 1 1.00000 0.00000 0 30 33 0 1 0 999 V2000 12.3088 -23.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.4648 -24.1980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.4648 -25.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.3088 -25.6599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.1530 -25.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.1530 -24.1980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.6208 -25.6599 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 13.9970 -23.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9970 -22.7360 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15.0703 -24.1980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.9970 -25.6599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9970 -26.6346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 14.7405 -25.2071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8411 -27.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.6853 -26.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8411 -28.0966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.6853 -28.5839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 16.5293 -28.0966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.5293 -27.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9970 -28.5839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.3380 -26.5203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.5256 -24.9543 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 16.8629 -25.6692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.2942 -26.3316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4102 -25.3638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 15.7436 -23.4158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.0089 -26.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.7237 -27.6569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 19.2613 -24.8888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.6426 -25.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 2 3 2 0 0 0 3 4 1 0 0 0 4 5 2 0 0 0 5 6 1 0 0 0 1 6 2 0 0 0 3 7 1 0 0 0 6 8 1 0 0 0 8 9 2 0 0 0 8 10 1 0 0 0 5 11 1 0 0 0 11 12 1 0 0 0 11 13 1 1 0 0 12 14 1 0 0 0 16 17 1 0 0 0 17 18 2 0 0 0 18 19 1 0 0 0 15 19 2 0 0 0 15 14 1 0 0 0 14 16 2 0 0 0 16 20 1 0 0 0 19 21 1 0 0 0 22 23 2 0 0 0 24 25 1 0 0 0 22 25 1 0 0 0 23 21 1 0 0 0 21 24 2 0 0 0 10 26 1 0 0 0 24 27 1 0 0 0 27 28 3 0 0 0 25 29 1 0 0 0 10 30 1 0 0 0 30 23 1 0 0 0 M END > CHEBI:143117 > lorlatinib > A cyclic ether that is 16,17-dihydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-15(10H)-one substituted by methyl groups at positions 2 and 10R, and by cyano, amino and fluoro groups at positions 3, 7 and 12 respectively. It is a small molecule inhibitor of ALK and ROS1 kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer. > 3 > PFE-PKIS 10; PF06463922; PF-06463922; loratinib > (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile > lorlatinibum; lorlatinib; lorlatinib; lorlatinib > Lorbrena > C21H19FN6O2 > 406.421 > 406.15535 > 0 > C=1C=C(C=C2C1C(=O)N(C)CC3=NN(C(=C3C=4C=NC(=C(O[C@@H]2C)C4)N)C#N)C)F > InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1 > IIXWYSCJSQVBQM-LLVKDONJSA-N > 1454846-35-5 > 1454846-35-5 > DB12130 > D11012 > 5P8 > Lorlatinib > 24819116; 25073473; 25349124; 25733882; 26698910; 26880581; 27413712; 28594000; 29744867; 30413378; 30478428; 30604291; 30816885 $$$$